Home/Filings/4/0001865778-25-000003
4//SEC Filing

Murphy Matthew B. 4

Accession 0001865778-25-000003

CIK 0001808805other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 6:34 PM ET

Size

5.5 KB

Accession

0001865778-25-000003

Insider Transaction Report

Form 4
Period: 2025-09-04
Murphy Matthew B.
General Counsel
Transactions
  • Purchase

    Common Stock

    2025-09-04$0.64/sh+20,000$12,85874,140 total(indirect: See Footnote)
Holdings
  • Common Stock

    1,250
Footnotes (1)
  • [F1]Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.

Issuer

Nautilus Biotechnology, Inc.

CIK 0001808805

Entity typeother

Related Parties

1
  • filerCIK 0001865778

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 6:34 PM ET
Size
5.5 KB